4.7 Article

The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Public, Environmental & Occupational Health

Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavirus disease 2019 (COVID-19)-specific intensive care unit

Danielle Rosani Shinohara et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study

Renato Pascale et al.

Summary: This study assessed the incidence of colonization and infection with CPE and CR-Ab in ICUs before and during the COVID-19 pandemic. The results showed no significant change in CPE colonization and infection, but a significant increase in CR-Ab colonization and infection. The CR-Ab strains belonged to the same clonal lineage and horizontal transmission was observed. Therefore, infection control activities should be conducted during the pandemic and adjusted according to the situation.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Immunology

Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study

Valerie M. Vaughn et al.

Summary: Among 1705 hospitalized COVID-19 patients, 56.6% received early empiric antibacterial therapy, while only 3.5% had confirmed community-onset bacterial infections. The use of early empiric antibacterials varied widely across hospitals.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

Marco Ripa et al.

Summary: The study aimed to describe the incidence and predictive factors of secondary infections in COVID-19 patients. Risk factors identified for secondary infections included low lymphocyte count, baseline PaO2/FiO2 decrease, and ICU admission within the first 48 hours.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Biochemistry & Molecular Biology

Effects of Steroids and Tocilizumab on the Immune Response Profile of Patients with COVID-19-Associated ARDS Requiring or Not Veno-Venous Extracorporeal Membrane Oxygenation

Vito Fanelli et al.

Summary: In critically ill COVID-19 patients with ARDS, concomitant therapies with steroids and Tocilizumab can reduce total leukocyte, lymphocyte, and subpopulation count, while the effect of Tocilizumab in increasing total lymphocytes and reducing procalcitonin might be affected by VV-ECMO.

MEMBRANES (2021)

Review Infectious Diseases

Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis

Jiating Liu et al.

Summary: The study showed that combination therapy with high-dose sulbactam and additional antibacterial agents had promising efficacy in treating MDR-AB or XDR-AB infections, while colistin-based combinations remained the mainstay in most studies. However, colistin combined with other antibacterial agents was associated with a higher risk of nephrotoxicity.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)

Article Infectious Diseases

Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome

Tommaso Bardi et al.

Summary: Co-infection of bacteria and fungi is common in ICU-admitted COVID-19 patients and usually presents as a severe form of infection, associated with a high mortality rate and longer ICU stay.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience

Arta Karruli et al.

Summary: This study found that in COVID-19 patients, those who stayed longer in the ICU and received steroid therapy were more susceptible to developing multidrug-resistant infections, but these infections did not result in worse outcomes.

MICROBIAL DRUG RESISTANCE (2021)

Article Infectious Diseases

Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19

Emilio Mariano Duran-Manuel et al.

Summary: The study identified and characterized the distribution and clonal spread of ESKAPE bacteria in medical devices, patients, and medical personnel in the ICU for COVID-19 patients at Hospital Juarez de Mexico. Acinetobacter baumannii and Staphylococcus aureus were the predominant ESKAPE members, with clonal spread of A. baumannii (AdeABCRS+) emphasizing the importance of implementing proper disinfection practices and management for COVID-19 patients.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2021)

Article Medicine, General & Internal

Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study

Daniele Roberto Giacobbe et al.

Summary: This study aimed to assess the incidence rate of ventilator-associated pneumonia in COVID-19 patients in intensive care units, finding that VAP is frequent and associated with a high fatality rate, likely due to the cumulative impact of the underlying viral disease and superimposed bacterial infections.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Virology

Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case-control study

Nosheen Nasir et al.

Summary: This study found that adverse outcomes in COVID-19 patients are often due to bacterial coinfection, with risk factors including critical illness at presentation and use of steroids. There is also a widespread use of empiric antibiotics in patients without bacterial infection.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Multidisciplinary Sciences

ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida

Eduardo Oliveira et al.

Summary: Our study in the largest healthcare system in Florida described the clinical characteristics and outcomes of severe COVID-19 patients admitted to ICU. The study showed that survivors of severe COVID-19 had longer durations of mechanical ventilation, hospital stay, and ICU stay compared to non-survivors.

PLOS ONE (2021)

Article Biochemistry & Molecular Biology

ECMO Support and Operator Safety in the Context of COVID-19 Outbreak: A Regional Center Experience

Giorgia Montrucchio et al.

Summary: This study developed a protocol in cooperation with infectious disease specialists, perfusionists, and cardiac surgeons to ensure operator safety during ECMO support for COVID-19 patients. By using specific equipment and conducting simulation training, ECMO support for COVID-19 patients was effectively carried out.

MEMBRANES (2021)

Review Critical Care Medicine

Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements

G. Montrucchio et al.

Summary: The review identified 21 English-language articles published before 2020, focusing on risk factors for COVID-19-associated pulmonary aspergillosis (CAPA), including host comorbidities, ICU management, and COVID-19 therapies. The results suggest that previous host risk factors, especially respiratory diseases, still play a crucial role; however, the attention is shifting from individual patient-related risk factors to factors characterizing hospital and ICU processes influenced by COVID treatment.

ANNALS OF INTENSIVE CARE (2021)

Article Public, Environmental & Occupational Health

A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit

Marianna Meschiari et al.

Summary: By reinforcing hand hygiene, extending screening, implementing contact precautions, increasing environmental sampling, and using a cycling radical environmental cleaning and disinfection procedure, the spread of CRAB in the ICU was effectively controlled. Cohorting, admission restrictions, or ICU closures were not necessary.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2021)

Review Microbiology

Acinetobacter baumannii Infections in Times of COVID-19 Pandemic

Karyne Rangel et al.

Summary: The COVID-19 pandemic has led to overuse of antimicrobials in critically ill patients, increasing the incidence of pathogens like Acinetobacter baumannii in ICUs. Patients with COVID-19 are at risk of secondary bacterial infections due to comorbidities and immune dysfunction.

PATHOGENS (2021)

Review Critical Care Medicine

Secondary infections in critically ill patients with COVID-19

Giacomo Grasselli et al.

Summary: This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2021, with more information available at the provided links.

CRITICAL CARE (2021)

Article Public, Environmental & Occupational Health

An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital

Tamar Gottesman et al.

Summary: This study describes an outbreak of carbapenem-resistant Acinetobacter baumannii (CRAB) in a COVID-19 dedicated hospital, with the suspected mechanism of transfer being an environmental source that persisted despite evacuation and terminal cleaning, transmitted through healthcare workers' hands or equipment. This outbreak highlights the importance of not neglecting practices to prevent the spread of multidrug-resistant organisms during the COVID-19 pandemic.

INFECTION PREVENTION IN PRACTICE (2021)

Editorial Material Infectious Diseases

COVID-19: don't neglect antimicrobial stewardship principles!

B. D. Huttner et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Editorial Material Medicine, General & Internal

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy Early Experience and Forecast During an Emergency Response

Giacomo Grasselli et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Infectious Diseases

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Bradley J. Langford et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Article Infectious Diseases

Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU

Ehsan Sharifipour et al.

BMC INFECTIOUS DISEASES (2020)

Article Infectious Diseases

Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball

G. Montrucchio et al.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)

Review Infectious Diseases

Managing Acinetobacter baumannii infections

Jose Garnacho-Montero et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2019)

Editorial Material Critical Care Medicine

ECDC definitions and methods for the surveillance of healthcare-associated infections in intensive care units

Diamantis Plachouras et al.

INTENSIVE CARE MEDICINE (2018)

Review Infectious Diseases

Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study

D. Koulenti et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)

Article Infectious Diseases

Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study

J. Masse et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)

Article Microbiology

Utility of Whole-Genome Sequencing in Characterizing Acinetobacter Epidemiology and Analyzing Hospital Outbreaks

Margaret A. Fitzpatrick et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2016)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Critical Care Medicine

Task force on management and prevention of Acinetobacter baumannii infections in the ICU

Jose Garnacho-Montero et al.

INTENSIVE CARE MEDICINE (2015)

Article Critical Care Medicine

Risk Factors and Outcome Analysis of Acinetobacter baumannii Complex Bacteremia in Critical Patients*

Hao-Yuan Lee et al.

CRITICAL CARE MEDICINE (2014)

Article Critical Care Medicine

Eighteen Years of Experience With Acinetobacter baumannii in a Tertiary Care Hospital

L. Silvia Munoz-Price et al.

CRITICAL CARE MEDICINE (2013)

Review Immunology

Acinetobacter baumannii An emerging opportunistic pathogen

Aoife Howard et al.

VIRULENCE (2012)

Article Public, Environmental & Occupational Health

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

Teresa C. Horan et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2008)